Quest for Research Freedom Fuels African Biotech Boom
Quest for Research Freedom Fuels African Biotech Boom
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Quest for Research Freedom Fuels African Biotech Boom
Quest for Research Freedom Fuels African Biotech Boom

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

industry collaboration
The Rise of BCI Enables Advances in Neuroscience
The Rise of BCI Enables Advances in Neuroscience
Jef Akst | Oct 1, 2020
A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.
Proposed Deep-Sea Mining Zone Harbors Previously Unknown Species
Proposed Deep-Sea Mining Zone Harbors Previously Unknown Species
Catherine Offord | Oct 17, 2019
The discovery of ancient clades of brittle stars at the bottom of the Pacific Ocean adds to concerns that commercial exploitation of the area could destroy numerous taxa before they’ve even been identified.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
How to Successfully Collaborate with Industry
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
The Rising Research Profile of 23andMe
The Rising Research Profile of 23andMe
Catherine Offord | Nov 30, 2017
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
Repurposing Existing Drugs for New Indications
Repurposing Existing Drugs for New Indications
Anna Azvolinsky | Jan 1, 2017
An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.
HHS Partners on Ebola Drug
HHS Partners on Ebola Drug
Jef Akst | Jul 22, 2015
The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.
CAR-T Therapies Get $1 Billion Boost
CAR-T Therapies Get $1 Billion Boost
Bob Grant | Jul 1, 2015
The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.
Follow the Funding
Follow the Funding
Bob Grant | May 1, 2015
In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.
 
23andMe Partners with Pfizer
23andMe Partners with Pfizer
Jef Akst | Jan 13, 2015
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
$230M for Big Disease
$230M for Big Disease
Jef Akst | Feb 5, 2014
The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.
Industry Funds Limit Freedom: Report
Industry Funds Limit Freedom: Report
Kerry Grens | Nov 27, 2013
A report by a Canadian organization finds that industry-academia relationships compromise university investigators' liberty.  
Innovation Nation
Innovation Nation
Megan Scudellari | Jul 1, 2013
Already a world leader in high-tech entrepreneurship, Israel is now flexing its biotech muscles.
Opinion: Bias Is Unavoidable
Lisa Cosgrove | Aug 7, 2012
Simply disclosing conflicts of interest is not enough.
Playing Fair with Industry
Sabrina Richards | Jun 13, 2012
The American Association of University Professors releases recommendations for maintaining academic freedom while collaborating with industry.